Ignite Creation Date:
2024-05-05 @ 11:35 AM
Last Modification Date:
2024-10-26 @ 9:10 AM
Study NCT ID:
NCT00080015
Status:
COMPLETED
Last Update Posted:
2020-04-29
First Post:
2004-03-19
Brief Title:
Diflomotecan BN80915 Administered Once Every 3 Weeks in Treating Patients With Sensitive Small Cell Lung Cancer SCLC
Sponsor:
Ipsen
Organization:
Ipsen
Organization Data
Organization:
Ipsen
Class:
INDUSTRY
Study ID:
2-91-52990-708
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Ipsen
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None